Deep Pharma Intelligence News Today

The investment parallels to the 90s … why today is an even better time to invest … two sectors that will soar based on AI … a special live AI event with Luke Lango tomorrow night

The application of AI in biology holds the potential to unlock enormous economic value for one simple reason – data.

We could live anywhere from 127 to 1000 this generation. And AI applied drug development could make this a reality.

The treatment is in mid-stage trials in the US and China with some results expected early 2025.

(Bloomberg) -- The global push to use artificial intelligence to find new medicines faces a crucial test as one front-runner starts approaching late-stage trials for a drug discovered by algorithms. Most Read from BloombergWall Street Divided Over Just How Aggressive Fed Cutting Will BeUBS Strategists See Far Deeper Fed Rate Cuts Than What Markets Are PricingIsrael Latest: Yellen Sees Limited Global Economic Impact So FarChina Weighs Ending Freeze on Boeing With 737 Max Deal in USBiden, Xi to An

Major pharmaceutical companies are increasingly turning to artificial intelligence (AI) to revolutionize drug development processes

During the last nine years, the cumulative amount of AI investments across the pharma and biotech sectors has increased by almost thirtyfold, to $24.6 billion as of last December.

Unveiling the Global State of AI in Cancer VaccinesNew Industry Report & IT-Platform Provide In-Depth Analysis of AI in Pharma17 August 2023AI in Cancer Vaccines 2023 MindmapAugust 17, 2023 - London, UK: Deep Pharma Intelligence, a leading BioTech market research agency focused on sophisticated analytics, benchm...

17 August 2023AI in Oncology 2023 Mindmap August 17, 2023 - London, UK:  Deep Pharma Intelligence, a leading BioTech market research agency focused on sophisticated analytics, benchmarking and forecasting of emerging and frontier domains in the Pharmaceutical, BioTech and Healthcare industries, today annou...

40% of Global AI Companies Focus on Early Drug Development while AI-Powered Startups Reshape the Future of Drug DiscoveryNew industry report from Deep Pharma Intelligence has redefined the Global State of AI in Drug DiscoveryAugust 16, 2023 - London, UK: The largest profiling of the global AI in the Drug Discovery i...